| Lung Cancer |
1 |
1 |
| Neoadjuvant Therapy |
0 |
0.61 |
| Chemotherapy |
0 |
0.59 |
| Non-Small Cell Lung Cancer |
0 |
0.99 |
| Adjuvant Chemotherapy |
0 |
0.43 |
| Surgery |
0 |
0.35 |
| Small Cell Lung Cancer |
0 |
0.34 |
| Biologic Therapy |
0 |
0.28 |
| Cancer |
0 |
0.26 |
| Genomic Medicine |
0 |
0.21 |
| Lung |
0 |
0.2 |
| Adjuvant Therapy |
0 |
0.09 |
| Immunotherapy |
0 |
0.09 |
| Platinum |
0 |
0.09 |
| Preoperative |
0 |
0.09 |
| Anaplastic Lymphoma Kinase |
0 |
0.06 |
| Epidermal Growth Factor Receptor |
0 |
0.06 |
| Grant |
0 |
0.06 |
| Smoking |
0 |
0.06 |
| Tobacco Cessation |
0 |
0.06 |
| Anxiety |
0 |
0.03 |
| Anxiety Disorder |
0 |
0.03 |
| Biomarker |
0 |
0.03 |
| Disease Recurrence |
0 |
0.03 |
| Histology |
0 |
0.03 |
| Jobs |
0 |
0.03 |
| Medical Life |
0 |
0.03 |
| Ohio |
0 |
0.03 |
| Postoperative |
0 |
0.03 |
| Radiation Therapy |
0 |
0.03 |
| Resection |
0 |
0.03 |
| Tumor |
0 |
0.03 |